The Latest Cardiac and Vascular News
IRVINE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures involving deep-brain stimulation, ablation, and gene and drug delivery today announced FDA Clearance of the ClearPoint PURSUIT […]
Record 629 ClearPoint® Procedures Performed in 2017 New Initiatives Position for Further Growth in 2018 IRVINE, Calif., March 15, 2018 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) (the “Company”) today announced financial results for the fourth quarter and full year ended […]
IRVINE, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) today announced the 2000th procedure completed with the ClearPoint NeuroNavigation System. The procedure was done by Dr. William Anderson at Johns Hopkins University. In the fall of 1998, a […]
IRVINE, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) today announced the appointment of Joseph Burnett as President and CEO, effective November 7. The company’s current President and CEO, Frank Grillo, will continue in the role until […]
IRVINE, Calif., July 11, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) (the “Company”), today announced preliminary results for its second quarter ended June 30, 2017. Reflecting accelerating utilization and an increasing number of ClearPoint sites, total revenue for the […]
IRVINE, Calif., May 11, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) is pleased to announce that John Fletcher has been appointed to MRI Interventions’ Board of Directors. Mr. Fletcher, founder and managing partner of Fletcher Spaght, Inc., brings more […]
IRVINE, Calif., April 24, 2017 (GLOBE NEWSWIRE) — MRI Interventions, Inc. (OTCQB:MRIC) today announced that the reduced patient risk associated with a One-Room, One-Procedure workflow for laser ablation has been reviewed in the journal of the American Society for Healthcare […]
